The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

Clinical trial NCT04541381 · SUSPENDED

Trial details

NCT number: NCT04541381
Sponsor: University of Chicago
Status: SUSPENDED
Phase: Not Applicable
Study type: INTERVENTIONAL

Gastrointestinal Cancer Head and Neck Cancer Dihydropyrimidine Dehydrogenase Deficiency UGT1A1 Gene Mutation Breast Cancer

Start date: 2022-02-07
Primary completion: 2027-10-01
Enrollment: 860

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.